February 24, 2008

EU regulators support pre-pandemic vaccine

The European Medicines Agency has recommended the approval of a vaccine designed to help people build immunity against the deadly bird flu virus.

The Wall Street Journal said the vaccine Prepandrix by GlaxoSmithKline is the first designed to be used before an outbreak occurs. The European Commission still must give final approval, the newspaper said Friday.

GlaxoSmithKline said a number of national governments have expressed interest in stockpiling the pre-pandemic H5N1 vaccine. The company said it plans to submit for U.S. Food and Drug Administration approval by the end of the year.

EU regulators support pre-pandemic vaccine

A better COVID treatment for the immunocompromised? Researchers create a non-toxic potential alternative to Paxlovid

Experimental drug shields pancreas from type 1 diabetes attack

Cabozantinib promising for advanced adrenocortical carcinoma

Clinical trial evaluates azithromycin for preventing chronic lung disease in premature babies

Targeting specific protein regions offers a new treatment approach in medulloblastoma

Treatment for deadly superbug C. diff may be weakening

National trial safely scales back prescribing of a powerful antipsychotic for the elderly

AI experts explore ethical use of video technology to support patients at risk of falls

Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based tests

Study sheds light on the debate around two types of shoulder replacement surgery for osteoarthritis

Study finds little gender difference in the perception of ambient room temperature

Researchers find difference in pancreatic cancer cells, offering new hope for immunotherapy effectiveness

Identifying risks of human flea infestations in plague-endemic areas of Madagascar

Closing the US/Mexico border during COVID-19 increased HIV transmission, study finds

Cardiologists train large AI model to assess heart structure, function

Deep-learning decoding for a noninvasive brain-computer interface

Study finds network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease

Brief anger may impair blood vessel function, says new research